These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinical experience with quinupristin-dalfopristin as rescue treatment of critically ill patients infected with methicillin-resistant staphylococci. Sander A, Beiderlinden M, Schmid EN, Peters J. Intensive Care Med; 2002 Aug; 28(8):1157-60. PubMed ID: 12185441 [Abstract] [Full Text] [Related]
6. Daptomycin for methicillin-resistant Staphylococcus epidermidis native-valve endocarditis: a case report. Duah M. Ann Clin Microbiol Antimicrob; 2010 Feb 18; 9():9. PubMed ID: 20167084 [Abstract] [Full Text] [Related]
13. Comparison of fosfomycin and vancomycin therapy for experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis. Rodríguez A, Vicente MV, Olay T. Eur J Clin Microbiol; 1985 Dec 18; 4(6):603-5. PubMed ID: 3853984 [No Abstract] [Full Text] [Related]
15. Long course of daptomycin in the treatment of meticillin-resistant Staphylococcus epidermidis endocarditis and spondylodiscitis. Bassetti M, Mikulska M, Schenone E, Nicolini L, Viscoli C. Int J Antimicrob Agents; 2009 Sep 18; 34(3):290-1. PubMed ID: 19423300 [No Abstract] [Full Text] [Related]
19. Synercid plus vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections: evaluation of 5 cases. Sgarabotto D, Cusinato R, Narne E, Scano F, Zignol M, Gambino A, Cattelan A, Meneghetti F, Cadrobbi P. Scand J Infect Dis; 2002 Jul 26; 34(2):122-6. PubMed ID: 11928842 [Abstract] [Full Text] [Related]
20. Comparative in vitro and in vivo efficacy of roxithromycin and erythromycin against a strain of methicillin-susceptible Staphylococcus epidermidis. Danias PG, Chalevelakis G, Mylonakis EE, Argyropoulou A, Paniara O, Saroglou G, Raptis SA. Diagn Microbiol Infect Dis; 1998 Sep 26; 32(1):51-4. PubMed ID: 9791758 [Abstract] [Full Text] [Related] Page: [Next] [New Search]